[ad_1]
The use of the Covid-19 vaccine, developed by the University of Oxford and AstraZeneca, was suspended in more than 20 countries on suspicion of causing blood clotting, while the European Medicines Agency (EMA) announced that the vaccine was “safe and effective”. Following the declaration of the EMA, the use of the vaccine was resumed in some countries, including Italy, Germany, the Netherlands, Spain and France, while the World Health Organization (WHO) discussed the safety issue of the AstraZeneca vaccine. in its present moment. meeting. Recalling that the World Health Organization (WHO) Advisory Committee on Global Vaccine Safety has met to review data on blood clots in some people with the Oxford-AstraZeneca vaccine, Tedros Adhanom Ghebreyesus, Director General of the WHO, said: “concluded that yes it does not indicate an increase”.
Ghebreyesus stated that people may have concerns about the safety of the AstraZeneca vaccine, “The AstraZeneca vaccine has great potential to prevent deaths. The Committee explained that the benefits of the vaccine outweigh the risks and infections caused by Covid-19. In This In this case, there is no question. Covid-19 is a deadly disease and the Oxford-AstraZeneca vaccine can prevent it. It is also important to remember that Covid-19 itself can cause blood clots, “he said.
“ASTRAZENECA IS 90 PERCENT OF COVAX”
Ghebreyesus emphasized that the AstraZeneca vaccine is extremely important, accounting for more than 90 percent of the vaccines distributed through Covax, a global initiative that aims to provide equitable access to the corona virus vaccine to all countries regardless of country. income level.
Ghebreyesus said he spoke with the leaders of the Organization of Eastern Caribbean States, “although most countries have managed to prevent a large number of infections and victims of Covid-19, their economies based mainly on tourism have largely disappeared. They have a clear message, ‘We need the Covid-19 vaccine and they need it now,’ “he noted.
Meeting with the Director General of the World Trade Organization Noting that he faces serious obstacles in the production and distribution of vaccines, Ghebreyesus announced that he will meet with Dr. Ngozi Okonjo-Iweala, Director General of the World Trade Organization, to increase the production of Covid-19 Vaccine next week.
